We thank Dr Nezic and colleagues for their interest in our work. They suggest that our conclusions on the relative patency of radial artery (RA) and saphenous vein (SV) grafts in diabetic patients 1 may differ if string sign grafts were considered occluded rather than patent. The predefined primary end point of the Radial Artery Patency Study 2,3 was the proportion of RA and SV grafts that were completely occluded at follow-up angiography, where complete occlusion was defined as the absence of visible opacification of the target coronary vessel (ie, Thrombolysis in Myocardial Infarction [TIMI] 0 flow). 4 Perfect graft patency (TIMI 3 flow) was a secondary angiographic end point, as was the presence of diffuse narrowing of the graft to Ͻ1 mm in diameter but with TIMI flow of at least 1 (ie, angiographic "string sign"). The study was planned in this manner because we expected the frequency of string sign to be Ͻ7.0%, the value observed. The inclusion criteria mandated that the proximal target vessel stenosis was Ͼ70%, and postoperative angiography was performed 1 year postoperatively rather than early after surgery. In addition, we considered complete occlusion a more definitive outcome.
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Using our original prespecified end point definitions, RA grafting was protective in the diabetic cohort We repeated our analysis twice to incorporate broader definitions of imperfect grafts, as suggested by Nezic and colleagues. We were mindful that our study was not adequately powered to analyze these end points, which we assume would diminish differences between conduits but only that of absolute 1-year patency. In the first analysis, string sign grafts with TIMI 1 were considered occluded, whereas in the second analysis, every string sign graft was counted as occluded.
Using a broader imperfect graft definition of TIMI 0 or TIMI 1 ϩ string sign, overall imperfect grafts were present in 51 of 440 RAs and 62 of 440 SVs (McNemar Pϭ0.26). Among diabetic patients, imperfect grafts (TIMI 0 or TIMI 1 ϩ string sign) were present in 13 of 115 RAs and 22 of 115 SVs (McNemar Pϭ0.09). Among nondiabetic patients, imperfect grafts (TIMI 0 or TIMI 1 ϩ string sign) were present in 38 of 325 RAs and 40 of 325 SVs (McNemar Pϭ0.8).
Using an even broader imperfect graft definition of TIMI 0 or any string sign, overall imperfect grafts were present in 67 of 440 RAs and 64 of 440 SVs (McNemar Pϭ0.8) . Among diabetic patients, imperfect grafts (TIMI 0 or any string sign) were present in 17 of 115 RAs and 23 of 115 SVs (McNemar Pϭ0.39) . Among nondiabetic patients, imperfect grafts (TIMI 0 or any string sign) were present in 49 of 325 RAs and 40 of 325 SVs (McNemar Pϭ0.37) .
Although diabetes was associated with poorer graft patency in our analysis, it was not an important risk variable of radial string sign: 6 of 115 in diabetic patients versus 25 of 325 in nondiabetic patients. We previously showed this finding in multivariate analysis as well. 5 In fully adjusted generalized estimating equation models of graft failure, diabetes was not a significant risk factor for either definition of imperfect grafts (TIMI 0 or TIMI 1 ϩ string sign: relative risk ϭ1.2, 95% confidence interval 0.9 to 1.7, Pϭ0.27; TIMI 0 or any string sign: relative risk ϭ1.2, 95% confidence interval 0.8 to 1.7, Pϭ0.31). This result was expected given the increasing relative influence of string signs on the patency end point and the lack of association between diabetes and string sign.
In summary, we conclude that at 1 year RA grafts provide improved overall graft patency in diabetic and nondiabetic patients; diabetes does not influence the incidence of RA string signs; and broader definitions of imperfect grafts that include string signs show similar results between conduits regardless of diabetic status.
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